|
Market Cap (5-Jun) $3,468,719 (1,786th) |
Close (30-Jun) $0.055 |
Volume (30-Jun) 26,598 |
Shortsold (27-Apr) 9,446 (0.01%) (422nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
AMT released this announcement to the ASX on 5 August 2022, 8:23. The announcement is not marked as price sensitive, and is 1 page(s) in length and 147.42kb in size.
You can view all announcements from AMT and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from AMT | |
|---|---|
| Extension of Loan Agreement with RIPL | 28 June 2023, 8:30 |
| Company Update on Sale of Orthopaedic Asset | 2 May 2023, 19:15 |
| AMT Submits 510(k) for Spinal Cage FDA Clearance | 31 March 2023, 8:21 |
| Biological Testing Sr-HT-Gahnite Further Safety Evidence | 5 August 2022, 8:23 |
| Notification of cessation of securities - AMT | 11 July 2022, 9:18 |
| Milestone Achieved Sr-HT-Gahnite Systemic Safety Evidence | 14 March 2022, 8:59 |
| Appendix 4D and Half Year Financial Report | 24 February 2022, 17:56 |
You must be logged in to post a reply.
